SRSF5 — Serine/Arginine Rich Splicing Factor 5
Overview
SRSF5 (Serine/Arginine Rich Splicing Factor 5), also known as SRp40 or SFRS5, is a member of the serine/arginine-rich (SR) protein family of RNA-binding proteins. These proteins are essential regulators of pre-mRNA splicing, playing critical roles in determining which exons are included or excluded during mRNA maturation. SRSF5 is encoded on chromosome 19q13.2 and is expressed ubiquitously across tissues, with particularly high expression in the nervous system. The protein consists of two RNA recognition motifs (RRMs) at its N-terminus and a characteristic C-terminal arginine/serine (RS) domain that facilitates protein-protein interactions and nuclear localization. This structural architecture makes SRSF5 a multifunctional protein capable of influencing pre-mRNA splicing decisions, mRNA export, and translation regulation.
Function and Biology
...SRSF5 — Serine/Arginine Rich Splicing Factor 5
Overview
SRSF5 (Serine/Arginine Rich Splicing Factor 5), also known as SRp40 or SFRS5, is a member of the serine/arginine-rich (SR) protein family of RNA-binding proteins. These proteins are essential regulators of pre-mRNA splicing, playing critical roles in determining which exons are included or excluded during mRNA maturation. SRSF5 is encoded on chromosome 19q13.2 and is expressed ubiquitously across tissues, with particularly high expression in the nervous system. The protein consists of two RNA recognition motifs (RRMs) at its N-terminus and a characteristic C-terminal arginine/serine (RS) domain that facilitates protein-protein interactions and nuclear localization. This structural architecture makes SRSF5 a multifunctional protein capable of influencing pre-mRNA splicing decisions, mRNA export, and translation regulation.
Function and Biology
SRSF5 functions primarily as a splicing regulator that binds to specific RNA sequences in pre-mRNA substrates, typically GAAGAA or similar purine-rich motifs. Upon RNA binding, SRSF5 recruits the spliceosome machinery to promote the inclusion of nearby exons, or alternatively, can suppress exon inclusion depending on its binding location and concentration. Beyond its classical splicing role, SRSF5 participates in multiple RNA metabolism processes including mRNA capping, polyadenylation, mRNA export through nuclear pore complexes, and translation initiation. The RS domain mediates interactions with other SR proteins and splicing factors, allowing SRSF5 to integrate into larger ribonucleoprotein complexes. Phosphorylation of serine residues in the RS domain by SR protein kinases (SRPKs) and topoisomerase I modulates SRSF5 activity and nuclear localization, providing dynamic regulation of splicing patterns in response to cellular conditions.
Role in Neurodegeneration
SRSF5 dysfunction has emerged as a critical factor in several neurodegenerative diseases, particularly in conditions involving abnormal RNA processing and protein aggregation. In spinal muscular atrophy (SMA), SRSF5 is integral to splicing regulation of the SMN gene; dysregulation of SRSF5 activity alters the balance between full-length SMN mRNA and delta-exon 7 variants, influencing disease severity. Similarly, SRSF5 abnormalities contribute to amyotrophic lateral sclerosis (ALS) pathogenesis, where the protein's altered function disrupts proper splicing of TARDBP, FUS, and other ALS-associated genes, exacerbating neurodegeneration. In Parkinson's disease, SRSF5 mislocalization and altered phosphorylation have been observed in cellular and animal models, correlating with impaired splicing of genes critical for dopaminergic neuron survival. The protein has also been implicated in frontotemporal dementia and other tauopathies through its role in regulating tau gene alternative splicing and the balance of tau isoforms that differ in microtubule-binding capacity.
Molecular Mechanisms
The pathogenic mechanisms involving SRSF5 in neurodegeneration operate through several interconnected pathways. Aberrant phosphorylation of SRSF5 can be triggered by neuroinflammation, oxidative stress, or toxic protein aggregates, leading to altered subcellular localization and loss of normal splicing function. Accumulation of misfolded proteins common in neurodegenerative diseases can sequester SRSF5 into inclusions, reducing its availability for splicing regulation. Additionally, SRSF5 interacts with neurotoxic proteins such as TDP-43 and FUS, and these interactions may be dysregulated in disease contexts, contributing to both splicing defects and proteinopathy. The protein also mediates splicing of anti-apoptotic and pro-autophagy genes; SRSF5 dysfunction can therefore skew cells toward apoptotic pathways and impair proteostasis mechanisms critical for neuronal survival.
Clinical and Research Significance
SRSF5 represents both a disease biomarker and a potential therapeutic target in neurodegeneration. Altered SRSF5 phosphorylation patterns and localization have been detected in patient-derived neurons and postmortem brain tissue from ALS and other neurodegenerative conditions. Modulating SRSF5 activity through small molecules that influence its phosphorylation state or RNA-binding properties shows promise in preclinical models of SMA and ALS. Understanding SRSF5-regulated splicing networks may reveal disease-specific therapeutic strategies to restore proper isoform ratios and proteostasis in neurodegeneration.
SRSF Family Members: SRSF1, SRSF2, SRSF3, SRSF4, SRSF6, SRSF7, SRSF9, SRSF10, SRSF11, SRSF12
**Associated Genes